First Trust Nasdaq Pharmaceuticals ETF
FTXH
71 hedge funds and large institutions have $985M invested in First Trust Nasdaq Pharmaceuticals ETF in 2026 Q3 according to their latest regulatory filings, with 42 funds opening new positions, 20 increasing their positions, 4 reducing their positions, and 1 closing their positions.
418,483% more capital inflows, than outflows
Capital inflows: $930M | Capital outflows: $222K
4,100% more first-time investments, than exits
New positions opened: 42 | Existing positions closed: 1
400% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 4
137% more funds holding
Funds holding: 30 → 71 (+41)
27.12% more ownership
Funds ownership: 65.08% → 92.2% (+27%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
First Trust Advisors
Wheaton,
Illinois
|
+$769M |
| 2 |
Nilsine Partners
Greenwood Village,
Colorado
|
+$21.2M |
| 3 |
NewEdge Advisors
New Orleans,
Louisiana
|
+$17.5M |
| 4 |
&Partners
Nashville,
Tennessee
|
+$13.7M |
| 5 |
Wells Fargo
San Francisco,
California
|
+$11M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IAIM
International Assets Investment Management
Orlando,
Florida
|
-$168K |
| 2 |
Marshall Investment Management
Littleton,
Colorado
|
-$28.7K |
| 3 |
Goldman Sachs
New York
|
-$21K |
| 4 |
OneDigital Investment Advisors
Overland Park,
Kansas
|
-$4.02K |
| 5 |
NBC Securities
Birmingham,
Alabama
|
-$40 |
FTXH Hedge Fund Activity: Q3 2026 in Review
71 of the 8,184 institutional investors tracked by Wall St. Rank reported a position in First Trust Nasdaq Pharmaceuticals ETF (FTXH) for Q3 2026, worth a combined $985M — up 4,070% from $23.6M a quarter earlier.
Buyers outnumbered sellers: 42 funds opened new FTXH positions and 1 closed out — a net gain of 41 holders — while 20 added to existing stakes and 4 trimmed.
The largest buyer was First Trust Advisors, opening a new position worth an estimated $769M. The largest seller was International Assets Investment Management, exiting entirely with an estimated $168K sold.
- 71 institutional investors held First Trust Nasdaq Pharmaceuticals ETF (FTXH) as of Q3 2026, up from 30 in Q2 2026.
- Funds reported $985M of First Trust Nasdaq Pharmaceuticals ETF stock for Q3 2026, up 4,070% quarter-over-quarter.
- 42 funds opened new First Trust Nasdaq Pharmaceuticals ETF positions in Q3 2026 and 1 closed out, a net change of +41 holders.
- The largest First Trust Nasdaq Pharmaceuticals ETF buyer in Q3 2026 was First Trust Advisors, an estimated $769M added.
- The largest First Trust Nasdaq Pharmaceuticals ETF seller in Q3 2026 was International Assets Investment Management, an estimated $168K sold.
Based on aggregated 13F filings for Q3 2026.